Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

74.85
BATS BZX Real-Time Price
As of 3:05pm ET
 -1.47 / -1.93%
Today’s Change
64.18
Today|||52-Week Range
83.79
+1.77%
Year-to-Date
10 Questions That Need to Be Asked Ahead of Johnson & Johnson's Q4 Report
Jan 23 / MotleyFool.com - Paid Partner Content
Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers
Jan 18 / TheStreet.com - Paid Partner Content
What's in Store for Abbott Labs (ABT) This Earnings Season?
Jan 20 / Zacks.com - Paid Partner Content
Eli Lilly Acquires CoLucid Pharma, Adds Migraine Drug to Pipeline
Jan 18 / TheStreet.com - Paid Partner Content
Camelot Portfolios, LLC Buys MTGE Investment Corp, AGNC Investment Corp, US Bancorp, ...
Jan 20 / GuruFocus News - Paid Partner Content
Stock Futures Seek Direction After Trump Rally Fades
Jan 18 / TheStreet.com - Paid Partner Content
Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?
Jan 20 / Zacks.com - Paid Partner Content
Drug companies pledge to improve emerging markets cancer care
Jan 18 / FT.com - Paid Partner Content
4 Drug Stocks Poised to Surprise this Earnings Season
Jan 20 / Zacks.com - Paid Partner Content
Gradient Investments LLC Buys Vanguard Short-Term Corporate Bond ETF, iShares TIPS Bo...
Jan 17 / GuruFocus News - Paid Partner Content
Celgene (CELG) Q4 Earnings: Will the Stock Pull a Surprise?
Jan 20 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Wells Fargo, Accenture, Eli Lilly, American Airlin...
Jan 17 / Zacks.com - Paid Partner Content
Here's Why CoLucid Pharmaceuticals Inc Popped Yesterday
Jan 19 / MotleyFool.com - Paid Partner Content
Company News for January 13, 2017
Jan 13 / Zacks.com - Paid Partner Content
Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?
Jan 19 / Zacks.com - Paid Partner Content
Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
Jan 13 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Q4 Earnings: Will the Stock Disappoint?
Jan 19 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan 13 / Zacks.com - Paid Partner Content
Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?
Jan 19 / Zacks.com - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
Lilly to Boost Migraine Pipeline with $960M CoLucid Buyout
Jan 19 / Zacks.com - Paid Partner Content
Lilly, Merck Expand Tie-Up to Study Lartruvo-Keytruda Combo
Jan 12 / Zacks.com - Paid Partner Content
Why Fastenal, Mead Johnson Nutrition, and CoLucid Pharmaceuticals Jumped Today
Jan 18 / MotleyFool.com - Paid Partner Content
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
Jan 11 / MotleyFool.com - Paid Partner Content
5 Expensive Drugs That Could End Up in Trump's Crosshairs
Jan 18 / MotleyFool.com - Paid Partner Content
Incyte's Prospects Get Even Brighter With Merck Announcement
Jan 10 / MotleyFool.com - Paid Partner Content
Stocks Struggle for Direction as Economic Improvements May Push Fed Moves
Jan 18 / TheStreet.com - Paid Partner Content
Eli Lilly's new chief seeks to recover from Alzheimer's drug flop
Jan 05 / FT.com - Paid Partner Content
What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings?
Jan 18 / Zacks.com - Paid Partner Content